MicroRNA expression linked to neoadjuvant chemo response

June 16, 2014
MicroRNA expression linked to neoadjuvant chemo response

(HealthDay)—Expression of the microRNA MiR-193a-5p, together with HGF and c-MET proteins, is associated with response to neoadjuvant chemotherapy (NACT) in ovarian cancer, according to a study published online June 13 in Oncotarget.

Marisa Mariani, Ph.D., from the Danbury Hospital Research Institute in Connecticut, and colleagues attempted to identify actionable mechanisms of resistance to NACT in patients with . MicroRNA expression was screened in a set of 85 patients. To analyze potential targets, significant correlations were calculated between microRNAs and genes. In a validation set of 109 patients, quantitative immunohistochemistry was employed to validate targets.

The researchers found that in the NACT setting, MiR-193a-5p was significantly overexpressed. This microRNA was also significantly correlated with HGF and MET genes in analysis of potential targets. In analysis of before and after NACT, both HGF and MET were found to be increased after NACT. The highest relative basal expression of HGF and c-MET was exhibited by patients who relapsed shortly after NACT, while the opposite phenomenon was seen in the best responders.

"Mir-193a-5p, HGF, and c-Met expression may help select eligible for this modality of treatment," the authors write. "Moreover, inhibitors of this pathway may improve the efficacy of NACT."

Explore further: Discovery predicts patient sensitivity to important drug target in deadly brain cancer

More information: Abstract
Full Text

Related Stories

Serum miR-21 putative biomarker for colorectal cancer

June 20, 2013

(HealthDay)—The oncogenic microRNA (miRNA) miR-21 is a potential biomarker for detection and prognosis of colorectal cancer (CRC), according to a study published in the June 19 issue of the Journal of the National Cancer ...

Researchers discover ovarian cancer biomarker

January 8, 2014

Researchers at Case Western Reserve University have identified a microRNA biomarker that shows promise in predicting treatment response in the most common form of ovarian cancer – a breakthrough that has the potential to ...

Circulating MicroRNAs linked to type 2 diabetes

February 7, 2014

(HealthDay)—Circulating microRNAs (miRNAs) are associated with type 2 diabetes (T2D), and their levels vary with insulin action, according to a study published online Jan. 29 in Diabetes Care.

Recommended for you

Malaria vaccine provides hope for a general cure for cancer

October 13, 2015

The hunt for a vaccine against malaria in pregnant women has provided an unexpected side benefit for Danish researchers, namely what appears to be an effective weapon against cancer. The scientists behind the vaccine aim ...

Breast cancer drug beats superbug

October 13, 2015

Researchers at University of California, San Diego School of Medicine and Skaggs School of Pharmacy and Pharmaceutical Sciences have found that the breast cancer drug tamoxifen gives white blood cells a boost, better enabling ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.